These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26408419)

  • 1. Unraveling the complexity of autophagy: Potential therapeutic applications in Pancreatic Ductal Adenocarcinoma.
    Gómez VE; Giovannetti E; Peters GJ
    Semin Cancer Biol; 2015 Dec; 35():11-9. PubMed ID: 26408419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
    Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
    Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.
    García-Reyes B; Kretz AL; Ruff JP; von Karstedt S; Hillenbrand A; Knippschild U; Henne-Bruns D; Lemke J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, autophagy and the pathogenesis of liver and pancreatic cancers.
    Aghajan M; Li N; Karin M
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):10-4. PubMed ID: 22320909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?
    Krantz BA; O'Reilly EM
    Clin Cancer Res; 2018 May; 24(10):2241-2250. PubMed ID: 29269376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up.
    Perera RM; Bardeesy N
    Cancer Discov; 2015 Dec; 5(12):1247-61. PubMed ID: 26534901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapies for Pancreatic Cancer and Hurdles Ahead.
    Aslan M; Shahbazi R; Ulubayram K; Ozpolat B
    Anticancer Res; 2018 Dec; 38(12):6591-6606. PubMed ID: 30504367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy as a therapeutic target in pancreatic cancer.
    Piffoux M; Eriau E; Cassier PA
    Br J Cancer; 2021 Jan; 124(2):333-344. PubMed ID: 32929194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
    Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
    Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CYB5A in pancreatic cancer prognosis and autophagy modulation.
    Giovannetti E; Wang Q; Avan A; Funel N; Lagerweij T; Lee JH; Caretti V; van der Velde A; Boggi U; Wang Y; Vasile E; Peters GJ; Wurdinger T; Giaccone G
    J Natl Cancer Inst; 2014 Jan; 106(1):djt346. PubMed ID: 24301457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inflammation in pancreatic cancer.
    Hausmann S; Kong B; Michalski C; Erkan M; Friess H
    Adv Exp Med Biol; 2014; 816():129-51. PubMed ID: 24818722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and function of autophagy in pancreatic cancer.
    Li J; Chen X; Kang R; Zeh H; Klionsky DJ; Tang D
    Autophagy; 2021 Nov; 17(11):3275-3296. PubMed ID: 33161807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways.
    Kaistha BP; Lorenz H; Schmidt H; Sipos B; Pawlak M; Gierke B; Kreider R; Lankat-Buttgereit B; Sauer M; Fiedler L; Krattenmacher A; Geisel B; Kraus JM; Frese KK; Kelkenberg S; Giese NA; Kestler HA; Gress TM; Buchholz M
    Cancer Res; 2016 Jan; 76(1):96-107. PubMed ID: 26669866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
    Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
    Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.